Genmab — Oktober 2022
-
Genmab and Scancell Announce Cancer Antibody Product Collaboration — First Disease Target Identified https://www.scancell.co.uk/genmab-and-scancell-announce-cancer-antibody-product-collaboration-—-first-disease-target-identified
-
yes, because of the old one is why i doubted, but it seems legit https://www.voxmarkets.co.uk/rns/announcement/ce23680d-baba-4c59-8799-148dc5f9cfe0/
-
Få overblik over de mange kommende regnskaber med Proinvestors Finanskalender. https://www.proinvestor.com/finanskalender
-
Genmab-middel tæt på blockbustersstatus – Novartis øger salget 172 pct https://medwatch.dk/Medicinal___Biotek/article14522664.ece
-
10 %
-
-
Godmorgen

-
Godmorgen

-
USA/lukning: Rentefald sendte aktier op - Tesla, Apple i front
-
-
Genmab: Janssen får godkendt middel
baseret på duobody https://www.proinvestor.com/investornyt/895264/genmab-janssen-far-godkendt-middel-baseret-pa-duobody-gent
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
(teclistamab-cqyv) for the treatment of adult patients with relapsed or refractory multiple myeloma